The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Ganjukov V.I.

State Research Institute for Complex Issues of Cardiovascular Diseases, Sosnovy Boulevard, Kemerovo, Russia

Popov V.A.

FGBU "Nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN", Moskva

Shukevich D.L.

Kemerovskaia oblastnaia klinicheskaia bol'nitsa

Khaes B.L.

URAMN nauchno-issledovatel'skiĭ institut kompleksnykh problem serdechno-sosudistykh zabolevaniĭ SO RAMN, Kemerovo

Barbarash L.S.

State Research Institute for Complex Issues of Cardiovascular Diseases Municipal Budget Healthcare Institution, Kemerovo, Russia

Hospital results of percutaneous coronary intervention with biventricular assisted circulation in combination with extracorporeal membrane oxygenation

Authors:

Ganjukov V.I., Popov V.A., Shukevich D.L., Khaes B.L., Barbarash L.S.

More about the authors

Read: 1429 times


To cite this article:

Ganjukov VI, Popov VA, Shukevich DL, Khaes BL, Barbarash LS. Hospital results of percutaneous coronary intervention with biventricular assisted circulation in combination with extracorporeal membrane oxygenation. Russian Journal of Cardiology and Cardiovascular Surgery. 2014;7(1):15‑20. (In Russ.)

References:

  1. Aragon J., Lee M.S., Kar S. et al. Tandemheart for high risk PCI. Catheter Cardiovas Interv 2005; 65: 3: 346-352.
  2. Burkhoff D., Cohen H., Brunckhorst C. et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 2006; 152: e1-e8.
  3. Burzotta F., Paloscia L., Trani C. et al. Feasibility and long-term safety of elective Impella-assisted high risk percutaneous coronary intervention: a pilot two-center study. J Cardiovasc Med 2008; 9: 1004-1010.
  4. Caracciolo E.A., Davis K.B., Sopko G. et al. Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience. Circulation 1995; 91: 2335-2344.
  5. Hillis L.D., Smith P.K., Anderson J.L. et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011; 58: 2584-2614.
  6. Jeremias A., Kaul S., Rosengart T.K. et al. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med 2009; 122: 152-161.
  7. Kappetein A.P., Mohr F.W., Feldman T.E. et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011; 17: 2125-2134.
  8. Kredish I., Davies D.W., Lim R. et al. High risk PCI with elective IABP support. Int J Cardiol 1992; 35: 2: 147-152.
  9. Mauri L., Hsieh W., Massaro J.M. et al. Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting Stents. N Engl J Med 2007; 356: 1020-1029.
  10. Nashef S.A., Roques F., Michel P. et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
  11. Serruys P.W., Morice M.C., Kappetein A.P. et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
  12. Sjauw K.D., Engstrom A.E., Vis M.M. et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J 2009; 30: 459-468.
  13. Sjauw K.D., Konorza T., Erbel R. et al. Supported high-risk percutaneous coronary intervention with the Impella 2.5 Device. The Europella Registry. J Am Coll Cardiol 2009; 54: 2430-2434.
  14. Thiele H., Smalling R.W. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2007; 28: 2057-2063.
  15. Toumpoulis I.K., DeRose J.J. European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting. Eur J Cardiothorac Surg 2004; 25: 1: 51-58.
  16. Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 20: 2501-2555.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.